Correlation Between Apogee Therapeutics, and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Apogee Therapeutics, and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apogee Therapeutics, and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apogee Therapeutics, Common and Spyre Therapeutics, you can compare the effects of market volatilities on Apogee Therapeutics, and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apogee Therapeutics, with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apogee Therapeutics, and Spyre Therapeutics.
Diversification Opportunities for Apogee Therapeutics, and Spyre Therapeutics
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Apogee and Spyre is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Apogee Therapeutics, Common and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Apogee Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apogee Therapeutics, Common are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Apogee Therapeutics, i.e., Apogee Therapeutics, and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Apogee Therapeutics, and Spyre Therapeutics
Given the investment horizon of 90 days Apogee Therapeutics, Common is expected to generate 1.26 times more return on investment than Spyre Therapeutics. However, Apogee Therapeutics, is 1.26 times more volatile than Spyre Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.19 per unit of risk. If you would invest 4,385 in Apogee Therapeutics, Common on September 26, 2024 and sell it today you would earn a total of 347.00 from holding Apogee Therapeutics, Common or generate 7.91% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Apogee Therapeutics, Common vs. Spyre Therapeutics
Performance |
Timeline |
Apogee Therapeutics, |
Spyre Therapeutics |
Apogee Therapeutics, and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Apogee Therapeutics, and Spyre Therapeutics
The main advantage of trading using opposite Apogee Therapeutics, and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apogee Therapeutics, position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.Apogee Therapeutics, vs. Fate Therapeutics | Apogee Therapeutics, vs. Caribou Biosciences | Apogee Therapeutics, vs. Karyopharm Therapeutics | Apogee Therapeutics, vs. Hookipa Pharma |
Spyre Therapeutics vs. Fate Therapeutics | Spyre Therapeutics vs. Caribou Biosciences | Spyre Therapeutics vs. Karyopharm Therapeutics | Spyre Therapeutics vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |